Sherry Y Wu

Sherry Y Wu

UNVERIFIED PROFILE

Are you Sherry Y Wu?   Register this Author

Register author
Sherry Y Wu

Sherry Y Wu

Publications by authors named "Sherry Y Wu"

Are you Sherry Y Wu?   Register this Author

52Publications

2075Reads

24Profile Views

Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells.

EBioMedicine 2019 May 2;43:127-137. Epub 2019 May 2.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.04.045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558231PMC
May 2019

Editorial: Advances and Challenges in Nanomedicine.

Front Pharmacol 2018 29;9:1397. Epub 2018 Nov 29.

School of Biomedical Sciences, University of Queensland, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2018.01397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281879PMC
November 2018

The Advances and Challenges in Utilizing Exosomes for Delivering Cancer Therapeutics.

Front Pharmacol 2018 16;9:735. Epub 2018 Jul 16.

School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2018.00735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055018PMC
July 2018

ADH1B promotes mesothelial clearance and ovarian cancer infiltration.

Oncotarget 2018 May 18;9(38):25115-25126. Epub 2018 May 18.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982754PMC
May 2018

Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.

Cell Rep 2017 Dec;21(10):2785-2795

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.11.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749980PMC
December 2017

Immune cell profiling in cancer: molecular approaches to cell-specific identification.

NPJ Precis Oncol 2017 15;1(1):26. Epub 2017 Aug 15.

1Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41698-017-0031-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871917PMC
August 2017

Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer.

Mol Cancer Ther 2017 05 21;16(5):966-976. Epub 2017 Feb 21.

Department of Chemical Engineering, University of Puerto Rico-Mayagüez, Mayagüez, Puerto Rico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0519DOI Listing
May 2017

Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers.

Cell Rep 2016 11;17(6):1621-1631

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, MDACC, Houston, TX 77030, USA; Department of Cancer Biology, MDACC, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.10.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123842PMC
November 2016

Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.

Methods Mol Biol 2016 ;1402:189-197

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3378-5_15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142631PMC
October 2016

Role of Increased n-acetylaspartate Levels in Cancer.

J Natl Cancer Inst 2016 Jan 26;108(6):djv426. Epub 2016 Jan 26.

Departments of Gynecologic Oncology and Reproductive Medicine (BZ, RAP, RR, TM, ASN, HJD, WH, CI, SYW, KMG, SP, LSM, AMN, GAP, AKS), Cancer Systems Imaging (NMZ, CRM, PKB), Biostatistics (MG), Cancer Medicine (CVP), Center for RNA Interference and Non-Coding RNA (CI, LSM, CRA, GLB, AKS), Cancer Biology (YS, MBE, GLB, AKS), Experimental Therapeutics (CRA, GLB), Bioinformatics and Computational Biology (YW, KAB), Melanoma Medical Oncology (MAD), and Pathology (JL), University of Texas M. D. Anderson Cancer Center, Houston, TX; Department of Nanomedicine and Bioengineering, UT Health, Houston, TX (GLB, AKS); Departments of Psychology, Urology, and Obstetrics and Gynecology, the University of Iowa, Iowa City, IA (SKL); Laboratory for Systems Biology of Human Diseases (LY, JB, AA, DN), Department of Chemical and Biomolecular Engineering (LY, JB, AA, DN), and Department of Bioengineering (DN), Rice University, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849357PMC
January 2016

Advances and Challenges of Liposome Assisted Drug Delivery.

Front Pharmacol 2015 1;6:286. Epub 2015 Dec 1.

The School of Biomedical Sciences and Pharmacy, The University of Newcastle Callaghan, NSW, Australia ; Hunter Medical Research Institute, New Lambton Heights NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2015.00286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664963PMC
December 2015

Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.

Cell Rep 2015 Dec 10;13(11):2395-2402. Epub 2015 Dec 10.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2015.11.047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691557PMC
December 2015

XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.

Clin Cancer Res 2015 Jul 15;21(14):3286-97. Epub 2015 Apr 15.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506247PMC
July 2015

Nanotechnology: Future of Oncotherapy.

Clin Cancer Res 2015 Jul;21(14):3121-30

Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1189DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505622PMC
July 2015

BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.

Mol Oncol 2014 Dec 6;8(8):1429-40. Epub 2014 Jun 6.

Department of Microbiology and Immunology, Western University, London, Ontario, Canada; Department of Oncology, Western University, London, Ontario, Canada; Department of Pathology, Western University, London, Ontario, Canada; Department of Physiology and Pharmacology, Western University, London, Ontario, Canada; Lawson Health Research Institute, London Health Sciences Centre, London, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.05.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528603PMC
December 2014

Therapeutic silencing of KRAS using systemically delivered siRNAs.

Mol Cancer Ther 2014 Dec 3;13(12):2876-85. Epub 2014 Oct 3.

Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-0074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416486PMC
December 2014

Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.

Nat Commun 2014 Oct 29;5:5202. Epub 2014 Oct 29.

1] Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA [2] Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA [3] Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215647PMC
October 2014

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

Cancer Cell 2014 Jul;26(1):77-91

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-coding RNA, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2014.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100212PMC
July 2014

Notch3 pathway alterations in ovarian cancer.

Cancer Res 2014 Jun 17;74(12):3282-93. Epub 2014 Apr 17.

Authors' Affiliations: Departments of Gynecologic Oncology and Reproductive Medicine, Systems Biology, Pathology, Experimental Therapeutics, Bioinformatics and Computational Biology, Cancer Biology, Thoracic/Head and Neck Medical Oncology, and The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TexasAuthors' Affiliations: Departments of Gynecologic Oncology and Reproductive Medicine, Systems Biology, Pathology, Experimental Therapeutics, Bioinformatics and Computational Biology, Cancer Biology, Thoracic/Head and Neck Medical Oncology, and The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TexasAuthors' Affiliations: Departments of Gynecologic Oncology and Reproductive Medicine, Systems Biology, Pathology, Experimental Therapeutics, Bioinformatics and Computational Biology, Cancer Biology, Thoracic/Head and Neck Medical Oncology, and The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-2066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058356PMC
June 2014

Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer.

Clin Cancer Res 2014 Jun 22;20(12):3280-8. Epub 2014 Apr 22.

Authors' Affiliations: Departments of Bioinformatics and Computational Biology, Gynecologic Oncology and Reproductive Medicine, Experimental Therapeutics, Cancer Biology, and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Fred Hutchinson Cancer Research Center, Seattle, WashingtonAuthors' Affiliations: Departments of Bioinformatics and Computational Biology, Gynecologic Oncology and Reproductive Medicine, Experimental Therapeutics, Cancer Biology, and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Fred Hutchinson Cancer Research Center, Seattle, WashingtonAuthors' Affiliations: Departments of Bioinformatics and Computational Biology, Gynecologic Oncology and Reproductive Medicine, Experimental Therapeutics, Cancer Biology, and Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Fred Hutchinson Cancer Research Center, Seattle, Washington

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-0445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062703PMC
June 2014

RNAi therapies: drugging the undruggable.

Sci Transl Med 2014 Jun;6(240):240ps7

Departments of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.

View Article

Download full-text PDF

Source
http://stm.sciencemag.org/cgi/doi/10.1126/scitranslmed.30083
Publisher Site
http://dx.doi.org/10.1126/scitranslmed.3008362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154139PMC
June 2014

The use of lipid-based nanocarriers for targeted pain therapies.

Front Pharmacol 2013 Nov 21;4:143. Epub 2013 Nov 21.

School of Biomedical Sciences and Pharmacy, The University of Newcastle Callaghan, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2013.00143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836271PMC
November 2013

Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer.

J Natl Cancer Inst 2013 Oct 23;105(19):1485-95. Epub 2013 Sep 23.

Affiliations of authors: Department of Gynecologic Oncology and Repro ductive Medicine (YK, WH, CI, CVP, HJD, BZ, TL, JH, NBJ, RR, MT, TM, SP, SYW, CL, YW, AKS), Center for RNAi and Non-Coding RNA (CI, AKS), Department of Pathology (JH, JL), and Department of Cancer Biology (AKS), The University of Texas MD Anderson Cancer Center, Houston, TX; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College of Fudan University, Shanghai, China (YK); Department of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (TL).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787907PMC
October 2013

siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo.

Immunol Cell Biol 2012 Feb 22;90(2):187-96. Epub 2011 Mar 22.

The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/icb.2011.19DOI Listing
February 2012

New roles opined for OPCML.

Cancer Discov 2012 Feb;2(2):115-6

Department of Gynecologic Oncology, Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-11-0356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854967PMC
February 2012

Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system.

J Control Release 2011 Nov 18;155(3):418-26. Epub 2011 Feb 18.

Diamantina Institute, University of Queensland, Princess Alexandra Hospital, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2011.02.002DOI Listing
November 2011

Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal Administration.

J Drug Deliv 2011 7;2011:192562. Epub 2011 Jun 7.

The University of Queensland Diamantina Institute, Princess Alexandra Hospital, The University of Queensland, Woolloongabba, QLD 4102, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/192562DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134833PMC
November 2011

Lipidic systems for in vivo siRNA delivery.

AAPS J 2009 Dec 9;11(4):639-52. Epub 2009 Sep 9.

Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Level 4, R-Wing, Princess Alexandra Hospital, Ipswich Rd, Buranda, QLD, 4102, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1208/s12248-009-9140-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782074PMC
December 2009

Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use.

Pharm Res 2009 Mar 21;26(3):512-22. Epub 2008 Nov 21.

Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Rd, Buranda, QLD 4102, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs11095-008-97
Web Search
http://link.springer.com/10.1007/s11095-008-9766-1
Publisher Site
http://dx.doi.org/10.1007/s11095-008-9766-1DOI Listing
March 2009